New advances in microsphere-based single-dose vaccines (Q33933148)

30 July 2017

title

New advances in microsphere-based single-dose vaccines (English)

1 reference

30 July 2017

1 reference

Langer R

1

1 reference

30 July 2017

Cleland JL

series ordinal

2

1 reference

30 July 2017

Hanes J

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 1997

1 reference

Advanced Drug Delivery Reviews

30 July 2017

published in

1 reference

30 July 2017

volume

28

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

97-119

1 reference

Adjuvants--a balance between toxicity and adjuvanticity

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Absence of protective immunity against diphtheria in a large proportion of young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Human immunization in developing countries: practical and theoretical problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Vaccines for the Third World

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

1 reference

7 January 2021

Vaccine delivery systems: potential methods for use in antifertility vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

A single-step immunization by sustained antigen release

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Subcuticular sutures and the rate of inflammation in noncontaminated wounds

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Absorbable pins of self-reinforced poly-L-lactic acid for fixation of fractures and osteotomies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Controlled delivery systems for proteins using polyanhydride microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Controlled release of polypeptides from polyanhydrides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Drug release from a new family of biodegradable polyanhydrides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Degradation of porous poly(anhydride-co-imide) microspheres and implications for controlled macromolecule delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Protein delivery from biodegradable microspheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

The development of polyanhydrides for drug delivery applications

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

A month-long effect from a single injection of microencapsulated human growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Release of human serum albumin from poly(lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Gamma irradiation effects on molecular weight and in vitro degradation of poly(D,L-lactide-CO-glycolide) microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Radiation Damage to Crystalline Ribonuclease: Identification of Polypeptide Chain Breakage in the Denatured and Aggregated Products

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Radiation Damage to Crystalline Ribonuclease: Importance of Free Radicals in the Formation of Denatured and Aggregated Products

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Parameters affecting the immunogenicity of microencapsulated tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Stability of protein pharmaceuticals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Biodegradable delivery system for a birth control vaccine: immunogenicity studies in rats and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Controlled-release vaccines--biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Pulsed controlled-released system for potential use in vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Determinants of release rate of tetanus vaccine from polyester microspheres.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

The effect of paraffin oil and mycobacteria on antibody formation and sensitization; a review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Structural and immunological characterization of the vaccine adjuvant QS-21.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Isomerization and formulation stability of the vaccine adjuvant QS-21

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Single-step immunization using a controlled release, biodegradable polymer with sustained adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Poly(anhydride) administration in high doses in vivo: studies of biocompatibility and toxicology.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Controlled protein delivery from biodegradable tyrosine-containing poly(anhydride-co-imide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Strategies for exploiting the immune system in the design of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Biodegradable microparticles for oral immunization.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Biodegradable microspheres as a vaccine delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Protection against vaginal SIV transmission with microencapsulated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Large porous particles for pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

The pharmacokinetics of pulmonary-delivered insulin: a comparison of intratracheal and aerosol administration to the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Pulmonary delivery of free and liposomal insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Paracrine cytokine adjuvants in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Murine interleukin-4 displays potent anti-tumor activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Delivery of liposome-encapsulated drugs to macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Immunological adjuvants: a role for liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Biological activity of liposome-encapsulated murine interferon gamma is mediated by a cell membrane receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

The pharmacokinetics of, and humoral responses to, antigen delivered by microencapsulated liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Lectin-bearing polymerized liposomes as potential oral vaccine carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Transepithelial transport and mucosal defence I: the role of M cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shigellosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: an ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Specific adherence of Escherichia coli (strain RDEC-1) to membranous (M) cells of the Peyer's patch in Escherichia coli diarrhea in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Intravaginal immunization in sheep using a bioadhesive microsphere antigen delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2897%2900053-7

7 January 2021

10.1016/S0169-409X(97)00053-7

Identifiers

DOI

1 reference

30 July 2017

1 reference